Trends in outpatient breast cancer surgery among Medicare fee-for-service patients in the United States from 1993 to 2002

John Bian, Michael Halpern

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The practice of outpatient breast cancer surgery has been controversial in the United States. This study aimed to update time trends and geographic variation in outpatient breast cancer surgery among elderly Medicare fee-for-service women in the United States. Using the 1993 -2002 linked Surveillance, Epidemiology and End Results (SEER)-Medicare claims data and the Area Resource Files, we identified 2 study samples, including the women whose breast cancers were the first-ever-diagnosed cancer at age 65 years or older from 9 regions continuously covered by the SEER registries since 1993. The first sample included the women receiving unilateral mastectomy for stage 0-IV cancer; the second included the women receiving the breast-conserving surgery with lymph node dissection (BCS/LND) for stage 0-II cancer. The proportions of patients receiving outpatient surgery increased from 3.2% to 19.4% for mastectomy and from 48.9% to 77.8% for BCS/LND from 1993 to 2002. We observed substantial geographic variation in the average proportion of the patients receiving outpatient surgery in the studied areas across the 10-year period, ranging from 3.9% in Connecticut to 27.2% in Utah for mastectomy and from 54.7% in Hawaii to 78.1% in Seattle, Washington, for BCS/LND. As the popularity of outpatient breast cancer surgery continues to grow, more evidence-based analyses related to quality and outcomes of outpatient breast cancer surgery among various populations are needed in order to facilitate the public debates about state and federal mandated health benefit legislations.

Original languageEnglish (US)
Pages (from-to)197-203
Number of pages7
JournalChinese Journal of Cancer
Volume30
Issue number3
StatePublished - 2011
Externally publishedYes

Fingerprint

Fee-for-Service Plans
Medicare
Outpatients
Segmental Mastectomy
Breast Neoplasms
Mastectomy
Lymph Node Excision
Ambulatory Surgical Procedures
Epidemiology
Neoplasms
Insurance Benefits
Legislation
Registries
Population

Keywords

  • Breast neoplasm
  • Mandated health benefit laws
  • Outpatient surgical procedures
  • Quality of care

ASJC Scopus subject areas

  • Oncology

Cite this

@article{1cfc49c8b5f84c65be495a1d8dae2e22,
title = "Trends in outpatient breast cancer surgery among Medicare fee-for-service patients in the United States from 1993 to 2002",
abstract = "The practice of outpatient breast cancer surgery has been controversial in the United States. This study aimed to update time trends and geographic variation in outpatient breast cancer surgery among elderly Medicare fee-for-service women in the United States. Using the 1993 -2002 linked Surveillance, Epidemiology and End Results (SEER)-Medicare claims data and the Area Resource Files, we identified 2 study samples, including the women whose breast cancers were the first-ever-diagnosed cancer at age 65 years or older from 9 regions continuously covered by the SEER registries since 1993. The first sample included the women receiving unilateral mastectomy for stage 0-IV cancer; the second included the women receiving the breast-conserving surgery with lymph node dissection (BCS/LND) for stage 0-II cancer. The proportions of patients receiving outpatient surgery increased from 3.2{\%} to 19.4{\%} for mastectomy and from 48.9{\%} to 77.8{\%} for BCS/LND from 1993 to 2002. We observed substantial geographic variation in the average proportion of the patients receiving outpatient surgery in the studied areas across the 10-year period, ranging from 3.9{\%} in Connecticut to 27.2{\%} in Utah for mastectomy and from 54.7{\%} in Hawaii to 78.1{\%} in Seattle, Washington, for BCS/LND. As the popularity of outpatient breast cancer surgery continues to grow, more evidence-based analyses related to quality and outcomes of outpatient breast cancer surgery among various populations are needed in order to facilitate the public debates about state and federal mandated health benefit legislations.",
keywords = "Breast neoplasm, Mandated health benefit laws, Outpatient surgical procedures, Quality of care",
author = "John Bian and Michael Halpern",
year = "2011",
language = "English (US)",
volume = "30",
pages = "197--203",
journal = "Cancer Communications",
issn = "1000-467X",
publisher = "BioMed Central Ltd.",
number = "3",

}

TY - JOUR

T1 - Trends in outpatient breast cancer surgery among Medicare fee-for-service patients in the United States from 1993 to 2002

AU - Bian, John

AU - Halpern, Michael

PY - 2011

Y1 - 2011

N2 - The practice of outpatient breast cancer surgery has been controversial in the United States. This study aimed to update time trends and geographic variation in outpatient breast cancer surgery among elderly Medicare fee-for-service women in the United States. Using the 1993 -2002 linked Surveillance, Epidemiology and End Results (SEER)-Medicare claims data and the Area Resource Files, we identified 2 study samples, including the women whose breast cancers were the first-ever-diagnosed cancer at age 65 years or older from 9 regions continuously covered by the SEER registries since 1993. The first sample included the women receiving unilateral mastectomy for stage 0-IV cancer; the second included the women receiving the breast-conserving surgery with lymph node dissection (BCS/LND) for stage 0-II cancer. The proportions of patients receiving outpatient surgery increased from 3.2% to 19.4% for mastectomy and from 48.9% to 77.8% for BCS/LND from 1993 to 2002. We observed substantial geographic variation in the average proportion of the patients receiving outpatient surgery in the studied areas across the 10-year period, ranging from 3.9% in Connecticut to 27.2% in Utah for mastectomy and from 54.7% in Hawaii to 78.1% in Seattle, Washington, for BCS/LND. As the popularity of outpatient breast cancer surgery continues to grow, more evidence-based analyses related to quality and outcomes of outpatient breast cancer surgery among various populations are needed in order to facilitate the public debates about state and federal mandated health benefit legislations.

AB - The practice of outpatient breast cancer surgery has been controversial in the United States. This study aimed to update time trends and geographic variation in outpatient breast cancer surgery among elderly Medicare fee-for-service women in the United States. Using the 1993 -2002 linked Surveillance, Epidemiology and End Results (SEER)-Medicare claims data and the Area Resource Files, we identified 2 study samples, including the women whose breast cancers were the first-ever-diagnosed cancer at age 65 years or older from 9 regions continuously covered by the SEER registries since 1993. The first sample included the women receiving unilateral mastectomy for stage 0-IV cancer; the second included the women receiving the breast-conserving surgery with lymph node dissection (BCS/LND) for stage 0-II cancer. The proportions of patients receiving outpatient surgery increased from 3.2% to 19.4% for mastectomy and from 48.9% to 77.8% for BCS/LND from 1993 to 2002. We observed substantial geographic variation in the average proportion of the patients receiving outpatient surgery in the studied areas across the 10-year period, ranging from 3.9% in Connecticut to 27.2% in Utah for mastectomy and from 54.7% in Hawaii to 78.1% in Seattle, Washington, for BCS/LND. As the popularity of outpatient breast cancer surgery continues to grow, more evidence-based analyses related to quality and outcomes of outpatient breast cancer surgery among various populations are needed in order to facilitate the public debates about state and federal mandated health benefit legislations.

KW - Breast neoplasm

KW - Mandated health benefit laws

KW - Outpatient surgical procedures

KW - Quality of care

UR - http://www.scopus.com/inward/record.url?scp=79954501251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954501251&partnerID=8YFLogxK

M3 - Article

C2 - 21352697

AN - SCOPUS:79954501251

VL - 30

SP - 197

EP - 203

JO - Cancer Communications

JF - Cancer Communications

SN - 1000-467X

IS - 3

ER -